Express Scripts (ESRX), Medco (MHS) Deal Likely to Pass FTC Scrutiny
Tweet Send to a Friend
Get Alerts ESRX Hot Sheet
Up)
Trade ESRX Now!
Express Scripts (Nasdaq: ESRX) is moving higher following a recent pop as the WSJ is reporting that the Federal Trade Commission (FTC) is unlikely to block its proposed merger with Medco Health (NYSE: MHS).
Though the FTC is said to still have concerns, people in the know told the WSJ that talks are currently going on to resolve the issues. Further, the FTC isn't gathering evidence or witness statements to file an antitrust case against the deal, amid requests to do so by several trade and consumer groups.
The FTC did not comment on the story and reps from Express Scripts and Medco have said they expect the $29 billion deal to close within the first half of 2012. Express Scripts is up over 2 percent while Medco is 1.9 percent better.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Though the FTC is said to still have concerns, people in the know told the WSJ that talks are currently going on to resolve the issues. Further, the FTC isn't gathering evidence or witness statements to file an antitrust case against the deal, amid requests to do so by several trade and consumer groups.
The FTC did not comment on the story and reps from Express Scripts and Medco have said they expect the $29 billion deal to close within the first half of 2012. Express Scripts is up over 2 percent while Medco is 1.9 percent better.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
- rue21 (RUE) Will be Acquired by Apax Partners for $42/Share
Create E-mail Alert Related Categories
Mergers and Acquisitions, Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
